Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

US Patent 10864173 · Granted Dec 15, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treatment of skin infections2023
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2023
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2023
Compositions and methods for treatment of skin infections2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022
Composition(s) and method(s) for topically treating pain2020
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2020
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2020
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2019
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2019
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of 2018